Attached files
| file | filename |
|---|---|
| 8-K - Vilacto Bio Inc. | mainbody.htm |
 |
January 8, 2019
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Dear Sir/Madam:
We have read the statements included under Item 4.01 in the Form 8-K dated January 7, 2019 of Vilacto Bio Inc. (the "Company") to be filed with the Securities and Exchange Commission and we agree with such statements insofar as they relate to our dismissal. We cannot confirm or deny that the appointment of Boyle CPA, LLC was approved by the Board of Directors, or that they were not consulted prior to their appointment as auditors.
Very truly yours,
/s/ AMC Auditing
AMC Auditing
Las Vegas, Nevada